Voloridge Investment Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-501,485
| Closed | -$20.3M | – | 1141 |
|
|
2025
Q1 | $20.3M | Buy |
+501,485
| New | +$20.3M | 0.08% | 356 |
|
|
2024
Q4 | – | Sell |
-91,984
| Closed | -$2.64M | – | 1158 |
|
|
2024
Q3 | $2.64M | Sell |
91,984
-101,852
| -53% | -$2.92M | 0.01% | 899 |
|
|
2024
Q2 | $4.55M | Buy |
+193,836
| New | +$4.55M | 0.02% | 782 |
|
|
2024
Q1 | – | Sell |
-174,222
| Closed | -$4.07M | – | 1129 |
|
|
2023
Q4 | $4.07M | Buy |
+174,222
| New | +$4.07M | 0.02% | 668 |
|
|
2023
Q2 | – | Sell |
-84,907
| Closed | -$3.25M | – | 1340 |
|
|
2023
Q1 | $3.25M | Sell |
84,907
-134,165
| -61% | -$5.13M | 0.02% | 822 |
|
|
2022
Q4 | $12M | Buy |
+219,072
| New | +$12M | 0.07% | 384 |
|
|
2020
Q4 | – | Sell |
-12,407
| Closed | -$382K | – | 1295 |
|
|
2020
Q3 | $382K | Buy |
+12,407
| New | +$382K | ﹤0.01% | 1131 |
|